Evidence map›Paper›PMID 40162201›Full record

ArticleRSC medicinal chemistry2025

Synthesis,

Gbolahan O Oduselu, Olayinka O Ajani, Temitope A Ogunnupebi, Oluwadunni F Elebiju, Damilola S Bodun, Oluwabukayo Toluwunmiju Opebiyi, Ezekiel Adebiyi

Abstract read
In one paragraph

Article in RSC medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gbolahan O OduseluCovenant University Bioinformatics Research (CUBRe), Covenant University Ota Nigeria ola.ajani@covenantuniversity.edu.ng.ORCID https://orcid.org/0000-0003-0136-1732
Olayinka O AjaniCovenant University Bioinformatics Research (CUBRe), Covenant University Ota Nigeria ola.ajani@covenantuniversity.edu.ng.ORCID https://orcid.org/0000-0002-3422-3478
Temitope A OgunnupebiCovenant University Bioinformatics Research (CUBRe), Covenant University Ota Nigeria ola.ajani@covenantuniversity.edu.ng.ORCID https://orcid.org/0000-0002-0744-7812
Oluwadunni F ElebijuCovenant University Bioinformatics Research (CUBRe), Covenant University Ota Nigeria ola.ajani@covenantuniversity.edu.ng.
Damilola S BodunCovenant University Bioinformatics Research (CUBRe), Covenant University Ota Nigeria ola.ajani@covenantuniversity.edu.ng.ORCID https://orcid.org/0000-0003-3440-8015
Oluwabukayo Toluwunmiju OpebiyiDepartment of Chemistry, Covenant University Km 10 Idiroko Road P.M.B. 1023 Ota Ogun State Nigeria.ORCID https://orcid.org/0009-0003-6066-5952
Ezekiel AdebiyiCovenant University Bioinformatics Research (CUBRe), Covenant University Ota Nigeria ola.ajani@covenantuniversity.edu.ng.ORCID https://orcid.org/0000-0002-1390-2359

Funding

WEST AFRICAN SUSTAINABLE LEADERSHIP AND INNOVATION TRAINING IN BIOINFORMATICS RESEARCH (WASLITBRe)U2RTW010679 · FIC · COVENANT UNIVERSITY · PI ADEBIYI, EZEKIEL FEMI, AMOAKO-YIRENKYI, PETER · 2017 to 2021
$1.4M
FIC NIH HHS U2R TW010679
6 · The paper itself

Abstract

Amidoximes are employed as building blocks to synthesise heterocyclic motifs with biological significance. They are very reactive and are used as prodrugs of amidine. This present study unveils the synthesis of amidoxime-based benzimidazole and benzimidamide motifs and evaluates their

Identifiers

PMID40162201
PMCPMC11950986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.